Last Item Added:

Press Releases



Keyword Search
 
2009 | 2008 | 2007 | 2006
DateDescriptionPrint
11/18/09Millipore Launches First Automated Cell Counter that Fits Into the Palm of the Hand
Provides precise cell counts and insights into cell health in just 20 seconds On Monday, December 7 at 7:30 a.m., in San Diego, Millipore will be hosting a press briefing to unveil a new and innovative instrument that will revolutionize cell counting for life science researchers. This transformational--and uniquely portable--technology provides a fast and accurate way of monitoring the health of cultures. John Sweeney, Vice President of Millipore's life science business, will present the in... 
Printer Friendly Version
11/12/09Millipore Corporation named Corporate Citizen of the Year
Corporate commitment to reduce global carbon footprint through clean energy is lauded BILLERICA, Mass.--(BUSINESS WIRE)--Nov. 12, 2009-- Millipore Corporation (NYSE: MIL) a leading provider of technologies, tools and services for the global life science industry has been named “Corporate Citizen of the Year” by the New England Clean Energy Council. The company’s commitment to reducing its global carbon footprint was ... 
Printer Friendly Version
11/05/09Millipore Reports Third Quarter 2009 Financial Results
Company generates 7 percent organic revenue growth and $112 million of free cash flow BILLERICA, Mass.--(BUSINESS WIRE)--Nov. 5, 2009-- Millipore Corporation (NYSE:MIL), a leading provider of technologies, tools and services for the global life science industry, today reported financial results for its third quarter ended October 3, 2009. Revenues for the third quarter grew 4 percent from the previous year, totaling $412 mi... 
Printer Friendly Version
10/19/09Millipore Advances Sustainability Strategy with Solar Energy Project
State and local dignitaries attend ribbon-cutting ceremonies in Bedford, Massachusetts BILLERICA, Mass.--(BUSINESS WIRE)--Oct. 19, 2009-- Millipore Corporation (NYSE:MIL), a Life Science leader providing technologies, tools and services for bioscience research and biopharmaceutical manufacturing, today announced the completion of a $2 million solar panel installation project at its Bedford, Massachusetts, facility. Millipore Chairman a... 
Printer Friendly Version
10/16/09Millipore Announces Date and Time of Third Quarter 2009 Earnings Release and Webcast
BILLERICA, Mass., Oct 16, 2009 (BUSINESS WIRE) -- Millipore Corporation (NYSE:MIL), a leading provider of technologies, tools and services for the global life science industry, today announced that it will disclose its third quarter financial results on Thursday, November 5, 2009, after the close of the stock market. The Company will webcast a conference call that evening to discuss its financial results, business outlook, and related corporate and financi... 
Printer Friendly Version
10/05/09Millipore Corporation Awards Flow Cytometer to Advance Cell Biology Research at Renowned Research Hospital
Mari Hashitate Dallas, MD, receives Millipore Guava flow cytometer for innovative research on umbilical cord blood transplants.BILLERICA, Mass., Oct 05, 2009 (BUSINESS WIRE) -- Millipore Corporation (NYSE: MIL), a Life Science leader providing technologies, tools and services for bioscience research and biopharmaceutical manufacturing, today awarded Dr. Mari Hashitate Dallas of St. Jude Children's Research Hospital in Memphis, Tenn., the Millipore Guava(R)... 
Printer Friendly Version
10/01/09Millipore Receives Award for Supply Consistency at Amgen Supplier Forum
Delivery, service and support efforts recognized BILLERICA, Mass.--(BUSINESS WIRE)--Oct. 1, 2009-- Millipore Corporation (NYSE: MIL), a leading provider of technologies, tools and services for the global life science industry, has received an award for “Supply Consistency” from Amgen Inc. The award was presented at a ceremony at Amgen’s biennial Operations Supplier Forum, held at the company’s headquarters in Thousand Oaks, CA. Millipore also... 
Printer Friendly Version
09/14/09Millipore and Roka Bioscience to Develop Real-Time Molecular Tests for Biopharmaceutical Applications
Creation of Roka Bioscience will accelerate development of new assays and portable instruments BILLERICA, Mass.--(BUSINESS WIRE)--Sep. 14, 2009-- Millipore Corporation (NYSE:MIL), a leading provider of technologies, tools and services for the global life science industry, today announced that it will collaborate with Roka Bioscience, Inc. to develop molecular assays and portable instruments for biopharmaceutical production. As recently... 
Printer Friendly Version
09/08/09Millipore to Webcast Presentation at Thomas Weisel Partners Healthcare Conference 2009
BILLERICA, Mass.--(BUSINESS WIRE)--Sep. 8, 2009-- Millipore Corporation (NYSE: MIL), a leading provider of technologies, tools and services for the global life science industry, today announced that it will webcast its presentation at the Thomas Weisel Partners Healthcare Conference on Wednesday, September 9, 2009 at 2:05 p.m. Eastern Time. The presentation will be given by Jean-Paul Mangeolle, Corporate Vice President and President Bioprocess Divisi... 
Printer Friendly Version
08/12/09Millipore Corporation Appoints New Vice President of Life Science Business Unit
John Sweeney to focus on technology development and partnerships BILLERICA, Mass.--(BUSINESS WIRE)--Aug. 12, 2009-- Millipore Corporation (NYSE: MIL), a leading provider of technologies, tools and services for the global life science industry, today announced the appointment of John Sweeney as Vice President of Millipore’s Life Science SBU. Most recently, Sweeney served as Vice President of Strategy and Marketing services for M... 
Printer Friendly Version
08/10/09Millipore Expands Drug Discovery and Development Services with BioAnaLab Acquisition
Acquisition extends Millipore’s biopharmaceutical services offering to European market BILLERICA, Mass.--(BUSINESS WIRE)--Aug. 10, 2009-- Millipore Corporation (NYSE:MIL), a leading provider of technologies, tools and services for the global life science industry, today announced it has acquired BioAnaLab, a European-based services provider that specializes in the analysis of biologic drugs and vaccines. The transaction enables Millipo... 
Printer Friendly Version
08/06/09Millipore Reports Second Quarter 2009 Financial Results
Performance highlighted by continued strength in Bioprocess Division and strong free cash flow Company increases full-year 2009 guidance for revenues, earnings and cash flow BILLERICA, Mass., Aug 06, 2009 (BUSINESS WIRE) -- Millipore Corporation (NYSE:MIL), a leading provider of technologies, tools and services for the global life science industry, today reported financial results for its second quarter ended July 4, 2009. Revenues for the second quarter declined 1 percent f... 
Printer Friendly Version
07/20/09Millipore Announces Date and Time of Second Quarter 2009 Earnings Release and Webcast
BILLERICA, Mass.--(BUSINESS WIRE)--Jul. 20, 2009-- Millipore Corporation (NYSE:MIL), a leading provider of technologies, tools and services for the global life science industry, today announced that it will disclose its second quarter financial results on Thursday, August 6, 2009, after the close of the stock market. The Company will webcast a conference call that evening to discuss its financial results, business outlook, and related corporate and f... 
Printer Friendly Version
07/10/09Millipore Sues W.L. Gore & Associates for Patent Infringement
BILLERICA, Mass., July 10, 2009 /PRNewswire via COMTEX/ -- Millipore Corporation, a leading provider of technologies, tools and services for the global life science industry, including bioscience research and biopharmaceutical manufacturing, has filed a lawsuit in the United States District Court for the District of Massachusetts, against W.L. Gore & Associates for infringement of Millipore's patent rights under U.S. Patent No. 7,293,477, "Disposable, Pre-Sterilized Fluid Receptacle Sampling... 
Printer Friendly Version
07/07/09Millipore Launches Next Generation of Flow Cytometers
Compact, affordable flow cytometer allows scientists to conduct complex cell analyses at their benchtops BILLERICA, Mass.--(BUSINESS WIRE)--Jul. 7, 2009-- Millipore Corporation (NYSE: MIL), a leading provider of technologies, tools and services for the global life science industry, today announced the launch of the new guava easyCyte™ 8HT flow cytometry system. This compact, affordable, six-color detection system with 96-well automation allows scien... 
Printer Friendly Version
06/12/09Millipore Unveils Its First Single-Use Bioreactor For Process Development
BILLERICA, Mass.--(BUSINESS WIRE)--Jun. 12, 2009-- Millipore Corporation (NYSE:MIL), a Life Science leader providing technologies, tools and services for bioscience research and biopharmaceutical manufacturing, introduces its new Mobius CellReady 3L Bioreactor. Co-developed under an agreement with Applikon Biotechnology, this ready-to-use three liter bioreactor requires no incremental capital investment, eliminates downtime and increases ... 
Printer Friendly Version
06/10/09Millipore Corporation Announces Appointment of Strategy and Corporate Development Vice President
Ram Ramakrishnan to lead Millipore's acquisition activities BILLERICA, Mass.--(BUSINESS WIRE)--Jun. 10, 2009-- Millipore Corporation (NYSE: MIL), a leading provider of technologies, tools and services for the global life science industry, today announced the appointment of Ram Ramakrishnan as Vice President, Strategy and Corporate Development. In his new role, Mr. Ramakrishnan is responsible for leading the development of Millipore’s corpora... 
Printer Friendly Version
06/09/09Millipore Opens New Bioprocess Manufacturing Facility in Massachusetts
State-of-the-art operation demonstrates commitment to disposable manufacturing BILLERICA, Mass.--(BUSINESS WIRE)--Jun. 9, 2009-- Millipore Corporation (NYSE:MIL), a leading provider of technologies, tools and services for the life science industry, today officially opened a new state-of-the-art manufacturing facility in Danvers, Massachusetts. The over 30,000 square foot facility will produce a wide range of the company’s Mobius® single-use product ... 
Printer Friendly Version
06/05/09Company Profile for Millipore Corporation
Millipore (NYSE: MIL) is a Life Science leader providing cutting-edge technologies, tools, and services for bioscience research and biopharmaceutical manufacturing. As a strategic partner, we collaborate with customers to confront the world’s challenging human health issues. From research to development to production, our scientific expertise and innovative solutions help customers tackle their most complex problems and achieve their goals. Milli... 
Printer Friendly Version
05/21/09Millipore to Webcast Investor Analyst Meeting
BILLERICA, Mass.--(BUSINESS WIRE)--May. 21, 2009-- Millipore Corporation (NYSE:MIL), a leading provider of technologies, tools and services for the global life science industry, today announced that it will host an Investor Analyst Meeting at the New York Stock Exchange on Wednesday, May 27, 2009 from 9:30 a.m. until 2:30 p.m. Eastern Daylight Time. A webcast of the meeting will be available on Millipore’s website beginning at 10:30 a.m. and lasting ... 
Printer Friendly Version
05/07/09Millipore Reports Strong First Quarter Financial Results and Raises Outlook for 2009
BILLERICA, Mass.--(BUSINESS WIRE)--May. 7, 2009-- Millipore Corporation (NYSE:MIL), a leading provider of technologies, tools and services for the global life science industry, today reported financial results for its first quarter ended April 4, 2009. Revenues for the first quarter grew 3 percent from the previous year, totaling $407.9 million. Excluding a 7 percent unfavorable impact from changes in foreign currency, revenues in the quart... 
Printer Friendly Version
05/06/09Millipore to Webcast Presentation at Bank of America and Merrill Lynch 2009 Health Care Conference
BILLERICA, Mass.--(BUSINESS WIRE)--May. 6, 2009-- Millipore Corporation (NYSE:MIL), a leading provider of technologies, tools and services for the global life science industry, today announced that it will webcast its presentation at the Bank of America and Merrill Lynch 2009 Health Care Conference on Wednesday, May 13, 2009 at 1:20 p.m. Eastern Time. The presentation will be given by Charles Wagner, Corporate Vice President and Chief Financial Offic... 
Printer Friendly Version
04/30/09Millipore to Webcast Annual Shareholder Meeting
BILLERICA, Mass.--(BUSINESS WIRE)--Apr. 30, 2009-- Millipore Corporation (NYSE:MIL), a leading provider of technologies, tools and services for the global life science industry, today announced that it will webcast its Annual Shareholder Meeting on Tuesday, May 12, 2009, beginning at 10:00 a.m. Eastern Time. The event will be held at Millipore Corporation’s headquarters in Billerica, MA. The presentation will be given by Martin Madaus, Chairman, Pres... 
Printer Friendly Version
04/22/09Millipore Demonstrates Leadership in Sustainability by Reducing Carbon Footprint 14 Percent
BILLERICA, Mass.--(BUSINESS WIRE)--Apr. 22, 2009-- Millipore Corporation (NYSE: MIL), a Life Science leader providing technologies, tools and services for bioscience research and biopharmaceutical manufacturing, today announced that it has reduced its carbon emissions 14 percent below its 2006 baseline. Most of the reductions were achieved since the company announced its global Sustainability Initiative in May 2008. Millipore&... 
Printer Friendly Version
04/15/09Millipore Announces Date and Time of First Quarter 2009 Earnings Release and Webcast
BILLERICA, Mass.--(BUSINESS WIRE)--Apr. 15, 2009-- Millipore Corporation (NYSE:MIL), a leading provider of technologies, tools and services for the global life science industry, today announced that it will disclose its first quarter financial results on Thursday, May 7, 2009, after the close of the stock market. The Company will webcast a conference call that evening to discuss its financial results, business outlook, and related corporate and finan... 
Printer Friendly Version
04/09/09Millipore and the University of Massachusetts Lowell Dedicate the Millipore Process Development Laboratory
BILLERICA, Mass., Apr 09, 2009 (BUSINESS WIRE) -- Millipore Corporation (NYSE:MIL), a Life Science leader providing technologies, tools and services for bioscience research and biopharmaceutical manufacturing, today announced the opening of the Millipore Corporation Process Development Laboratory in partnership with the University of Massachusetts (UMass) Lowell. Jean-Paul Mangeolle, President of Millipore's Bioprocess Division and Univers... 
Printer Friendly Version
04/06/09Millipore Corporation and Novozymes Biopharma Launch Innovative CellPrimeTM Product for Large Scale Industrial Cell Culture
BILLERICA, Mass. & NOTTINGHAM, United Kingdom, Apr 06, 2009 (BUSINESS WIRE) -- Millipore Corporation (NYSE:MIL) and Novozymes Biopharma (CSE: NZYMB) today announced the launch of CellPrimeTM rAlbumin AF-G, a completely animal-free cell culture supplement designed for large scale industrial bioprocessing applications. This groundbreaking product will be showcased at the Millipore booth (#107) and the Novozymes Biopharma booth (#207) at the Protein E... 
Printer Friendly Version
04/02/09Millipore Announces Availability of Proxy Materials for its 2009 Annual Shareholder Meeting
BILLERICA, Mass.--(BUSINESS WIRE)--Apr. 2, 2009-- Millipore Corporation (NYSE: MIL), a leading provider of technologies, tools and services for the global life science industry, today announced that the Company’s proxy materials for its 2009 Annual Shareholder Meeting are now available on its website. Shareholders can access Millipore’s 2008 annual report on Form 10-K and its proxy statement for the 2009 Annual Shareholder Meeting by clicking... 
Printer Friendly Version
03/19/09Millipore Partners with the American Cancer Society
$20,000 Grant Addresses Challenging Human Health Issue BILLERICA, Mass.--(BUSINESS WIRE)--Mar. 19, 2009-- Millipore Corporation a Life Science leader providing technologies, tools and services for bioscience research and biopharmaceutical manufacturing, today announced it will partner with the American Cancer Society to support critical research and awareness programs dedicated to combating cancer. Through this partnership, Millipore’s Corpor... 
Printer Friendly Version
03/17/09Millipore Unveils Industry's Most Integrated Single-Use Manufacturing Solutions at INTERPHEX 2009
Mobius(R) FlexReady Solutions provide unparalleled operational flexibility for single-use biomanufacturing BILLERICA, Mass.--(BUSINESS WIRE)--Mar. 17, 2009-- Millipore Corporation (NYSE:MIL), a Life Science leader providing technologies, tools and services for bioscience research and biopharmaceutical manufacturing, today officially launched its Mobius FlexReady Solutions at Interphex 2009 in New York. Mobius FlexReady Solutions represent a significant ... 
Printer Friendly Version
03/13/09Millipore to Webcast Presentation at Cowen and Company 29th Annual Health Care Conference
BILLERICA, Mass.--(BUSINESS WIRE)--Mar. 13, 2009-- Millipore Corporation (NYSE:MIL), a leading provider of technologies, tools and services for the global life science industry, today announced that it will webcast its presentation at the Cowen and Company 29th Annual Health Care Conference on Wednesday, March 18, 2009 at 9:30 a.m. Eastern Time. The presentation will be given by Charles Wagner, Corporate Vice President and Chief Financial Officer, an... 
Printer Friendly Version
03/09/09Millipore Corporation Supports Presidential Order On Stem Cell Research
BILLERICA, Mass., Mar 09, 2009 (BUSINESS WIRE) -- Millipore Corporation (NYSE:MIL), a provider of technologies, tools and services for the global life science industry, is supporting an executive order signed by President Barack Obama at the White House today, which rescinds limits on federal funding of stem cell research. Millipore is a leading provider of stem cell products to the biomedical research community. "President Obama's executive order... 
Printer Friendly Version
02/26/09Millipore Announces Technology Acquisition to Strengthen Drug Discovery Product Offering
Purchase will accelerate development of multiplex immunoassays for cell signaling BILLERICA, Mass.--(BUSINESS WIRE)--Feb. 26, 2009-- Millipore Corporation (NYSE: MIL), a leading provider of technologies, tools and services for the global life science industry, today announced that it has purchased the assets associated with Epitome Biosystems’ EpiTag™ technology. The purchase price was not disclosed. The technology acquisition will enable Mi... 
Printer Friendly Version
02/16/09Millipore Corporation Opens New Facility in Singapore
SINGAPORE & BILLERICA, Mass.--(BUSINESS WIRE)--Feb. 16, 2009-- Millipore Corporation (NYSE:MIL) a leading provider of technologies, tools and services for the global life science industry, today opened its state-of-the-art Biomanufacturing Sciences and Training Center (BSTC) in Singapore. The 8,000 square foot facility will provide support and technical service to Millipore’s biopharmaceutical customers who have operations throughout... 
Printer Friendly Version
02/05/09Millipore Reports Fourth Quarter and Full Year 2008 Financial Results
Company delivers exceptional cash flow performance; Bioscience Division continues strong growthBILLERICA, Mass., Feb 05, 2009 (BUSINESS WIRE) -- Millipore Corporation (NYSE:MIL), a leading provider of technologies, tools and services for the global life science industry, today reported financial results for its fourth quarter and full year ended December 31, 2008. Revenues for the fourth quarter declined 2 percent from the previous year, totaling $396.8 million. ... 
Printer Friendly Version
02/02/09Millipore Expands Cell Biology Offering With Acquisition of Guava Technologies
Acquisition will enable Millipore to bring the power of flow cytometry to all cell biologists' benchtopsBILLERICA, Mass., Feb 02, 2009 (BUSINESS WIRE) -- Millipore Corporation (NYSE: MIL), a leading provider of technologies, tools and services for the global life science industry, today announced that it has entered into an agreement to acquire Guava Technologies (Guava), a provider of easy-to-use, bench top cell analysis systems. The acquisition follows t... 
Printer Friendly Version
01/20/09Millipore Announces Date and Time of Fourth Quarter and Fiscal Year 2008 Earnings Release and Webcast
BILLERICA, Mass.--(BUSINESS WIRE)--Jan. 20, 2009--Millipore Corporation (NYSE: MIL), a Life Science leader providing technologies, tools and services for bioscience research and biopharmaceutical manufacturing, today announced that it will disclose its fourth quarter and fiscal year 2008 financial results on Thursday, February 5, 2009, after the close of stock market. The Company will webcast a conference call that evening to discuss its financial results, ... 
Printer Friendly Version
01/12/09Millipore Corporation Supports President-Elect Obama's Plans to Review Stem Cell Research Policy
BILLERICA, Mass., Jan 12, 2009 (BUSINESS WIRE) -- Millipore Corporation (NYSE:MIL), a leading provider of technologies, tools and services for the global life science industry, today announced it would support President-elect Barack Obama's plans to review and possibly reverse an executive order that currently restricts federal funding for embryonic stem cell research. The comments were made by Millipore Chairman, President and CEO Martin Madaus at... 
Printer Friendly Version
01/08/09Millipore Welcomes New Bioscience Division President
Jon DiVincenzo Officially Assumes New RoleBILLERICA, Mass., Jan 08, 2009 (BUSINESS WIRE) -- Millipore Corporation (NYSE: MIL), a life science leader providing technologies, tools and services for bioscience research and biopharmaceutical manufacturing, officially welcomes Jon DiVincenzo as President of its Bioscience Division and member of its Corporate Executive Committee. Mr. DiVincenzo assumed his new role on January 1, 2009, succeeding Dominique Baly,... 
Printer Friendly Version


IR CONTACT

Joshua S. Young
Director, Investor Relations
Tel: 978-715-1527
Joshua_Young@millipore.com

icon

IR SERVICES

Sign up for company alerts and download reports.

MIL (Common Stock)
11/20/09 4:02 p.m. ET
iconRefresh quote
Price$67.73
Change - 0.22
Volume656,067
20 minutes delayed

Safe Harbor Statement

The information on the Millipore investor relations website, as well as in future oral and written statements by management of Millipore Corporation that are forward-looking statements, are based on current management expectations that involve substantial risks and uncertainties which could cause actual results to differ materially from the results expressed in, or implied by, these forward-looking statements.

» More